demonstrated through cell proliferation assays, in vitro knockouts, and subcutaneous tumorigenesis experiments that HNRNPA2B1 promotes multiple myeloma (MM) cell proliferation and inhibits apoptosis in both in vivo and in vitro settings. Here, HNRNPA2B1 is linked to Miyoshi myopathy.